Jefferies upgraded Novozymes to Buy from Hold with a price target of DKK 420, up from DKK 380. The company’s growth is supported by fiscal 2024 destocking, its Protein investment and Bioenergy secular tailwinds, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVZMY:
